Fatal Leptospirosis Case in Pediatric Patient: Clinical Case


Introduction: Leptospirosis is a worldwide zoonosis. It is transmitted through the urine of infected animals. Currently, there is an increase of reports in many countries. In humans, it presents an ample clinical spectrum, which goes from an asymptomatic infection up to Weil syndrome, which is generally fatal. Clinical Case: A male, 6 years of age, who started with onset fever and jaundice, handled in private means, diagnosed as viral hepatitis “A” and was referred to an institutional hospital where hepatomegaly and splenomegaly were detected. His evolution was towards graveness and, therefore, he was referred to a third level hospital with reactive Hepatitis diagnosis and to rule out lymphoma. On admission, he presented liver and kidney failure, as well as metabolic acidosis and pulmonary haemorrhage that led to death 6 hours later. Confirmatory tests for hepatitis were negative; biopsies were taken post-mortem for Leptospira diagnosis, which were positive in liver and kidney. Conclusions: Leptospirosis is a disease that may be manifested in multiple ways. It is important the understanding of this disease by the physician to improve the diagnosis and, for general population, to avoid exposure. The examination of the epidemiological history of the patient is essential.

Share and Cite:

L. García, C. Cruz, I. Lugo, B. Sánchez, O. Castrejón and J. Espinosa, "Fatal Leptospirosis Case in Pediatric Patient: Clinical Case," Open Journal of Medical Microbiology, Vol. 3 No. 1, 2013, pp. 12-17. doi: 10.4236/ojmm.2013.31003.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] A. R. Bharti, J. E. Nally, J. N. Ricaldi, M. A. Matthias, M. M. Diaz, M. A. Lovett, et al., “Leptospirosis: A Zoonotic Disease of Global Importance,” Lancet Infectious Diseases, Vol. 3, No. 12, 2003, pp. 757-771. doi:10.1016/S1473-3099(03)00830-2
[2] R. A. Hartskeerl, “International Leptospirosis Society: Objetives and Achievements,” Revista Cubana de Medicina Tropical, Vol. 57, No. 1, 2005, pp. 7-10.
[3] I. A. Vado-Solís, M. A. Cárdenas-Marrufo, H. LaviadaMolina, F. Vargas-Puerto, J. E. B. Jiménez-Delgadillo y Zavala-Velázquez, “Estudio de Casos Clínicos e Incidencia de Leptospirosis Humana en el Estado de Yucatán, México Durante el Periodo de 1998-2000,” Revista Biomédica, Vol. 13, No. 3, 2002, pp. 157-164.
[4] C. B. Leal-Castellanos, R. García-Suárez, E. GonzálezFigueroa, J. L. Fuentes-Allen and J. Escobedo-De la Pe?a “Risk Factors and the Prevalence of Leptospirosis Infection in a Rural Community of Chiapas, México,” Epidemiol Infect, Vol. 131, No. 3, 2003, pp. 1149-1156. doi:10.1017/S0950268803001201
[5] N. E. Joel, M. M. Maribel, R. S. Beatriz and V. C. Oscar, “Leptospirosis Prevalence in a Population of Yucatan, Mexico,” Journal of Pathogens, Vol. 2011, 2011, Article ID: 408604.
[6] G. Varela and V. J. Zavala, “Estudio Serológico de la Leptospirosis en la República Mexicana,” Revista del Instituto de Salubridad y Enfermedades Tropicales, Vol. 21, 1961, pp. 49-52.
[7] P. N. Levett, “Leptospirosis,” In: Mandell, Douglas and Bennett’s, Eds, Principles and Practice of Infectious Diseases, 6th Edition, Elsevier, Churchill Livingstone, 2005, pp. 2789-2795.
[8] O. Velasco-Castrejón, B. Rivas-Sánchez and H. H. RiveraReyes, “Leptospirosis Humana Crónica,” In: J. NarroRobles, O. Rivero-Serrano and J. J. López Bárcena, Eds., Diagnóstico y Tratamiento en la Práctica Médica, 2nd Edition, Manual Moderno, México, 2006, pp. 641-650.
[9] C. O. Velasco, S. B. Rivas, J. Espinoza, J. Jiménez and E. Ruiz, “Enfermedades Simuladas y Acompa?antes de Leptospirosis,” Revista Cubana de Medicina Tropical, Vol. 57, No. 1, 2005, pp. 75-76
[10] M. S. Hernández, G. R. Menéndez, O. M. Torres, J. L. M. Alonso and J. M. A. Sánchez, “Leptospirosis en Ni?os de una Provincia Cubana,” Revista Mexicana de Pediatría, Vol. 73, No. 1, 2006, pp. 14-17.
[11] S. J. Pérez, O. J. Colin, S. A. Caballero and E. A. Cuellar, “Seropositividad a Leptospiras de Pacientes Sospechosos de Hepatitis Viral Negativos a Marcadores Serológicos,” Revista Cubana de Medicina Tropical, Vol. 57, No. 1, 2005, pp. 57-58.
[12] R. T. Trevejo, P. J. G. Rigau, D. A. Ashford, E. M. McClure, G. C. Jarquin, J. J. Amador, et al., “Epidemic Leptospirosis Associated with Pulmonary Hemorrhage-Nicaragua 1995,” The Journal of Infectious Diseases, Vol. 178, No. 5, 1998, pp. 1457-1463. doi:10.1086/314424
[13] C. Manuel, T. Rafael, B. Lourdes, G. Dana, G. Martha and V. J. M. Brote de, “Leptospirosis Asociado a la Natación en una Fuente de Agua Subterránea en Una Zona Costera, Lima-Perú,” Revista Peruana de Medicina Experimental y Salud Pública, Vol. 26, No. 4, 2009, pp. 441-448.
[14] J. Pradutkanchana, S. Pradutkanchana, M. Kemapanmanus, N. Wuthipum and Silpapajakul, “The Etiology of Acute Pirexia of Unknown Origin in Children after a Flood,” The Southeast Asian Journal of Tropical Medicine and Public Health, Vol. 34, No. 1, 2003, pp. 175-178.
[15] E. J. Sanders, J. G. Rigau-Perez, H. L. Smits, C. C. Deseda, V. A. Vorndam, T. Aye, et al.. “Increase of Leptospirosis in Dengue Negative Patients after a Hurricane in Puerto Rico in 1966,” The American Journal of Tropical Medicine and Hygiene, Vol. 61, No. 3, 1999, pp. 399-404.
[16] O. Velasco-Castrejón, B. Rivas-Sánchez, E. Gutiérrez, L. Chávez, P. Duarte, S. Chavarría, et al., “Leptospira Simulador o Causante de Leucemia?” Revista Cubana de Medicina Tropical, Vol. 57, No. 1, 2005, pp. 17-24.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.